Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Sep 5;11(17):5241.
doi: 10.3390/jcm11175241.

Mechanical Circulatory Support Devices for the Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction-A Review

Sharon Bruoha  1 , Chaim Yosefy  1 , Louay Taha  2 , Danny Dvir  2 , Mony Shuvy  2   3 , Rami Jubeh  2 , Shemy Carasso  2   4 , Michael Glikson  2   3 , Elad Asher  2
Affiliations
Review

Mechanical Circulatory Support Devices for the Treatment of Cardiogenic Shock Complicating Acute Myocardial Infarction-A Review

Sharon Bruoha et al. J Clin Med. .

Abstract

Cardiogenic shock complicating acute myocardial infarction is a complex clinical condition associated with dismal prognosis. Routine early target vessel revascularization remains the most effective treatment to substantially improve outcomes, but mortality remains high. Temporary circulatory support devices have emerged with the aim to enhance cardiac unloading and improve end-organ perfusion. However, quality evidence to guide device selection, optimal installation timing, and post-implantation management are scarce, stressing the importance of multidisciplinary expert care. This review focuses on the contemporary use of short-term support devices in the setting of cardiogenic shock following acute myocardial infarction, including the common challenges associated this practice.

Keywords: acute myocardial infarction; cardiogenic shock; mechanical circulatory support.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Schematic drawing of commercially available left ventricular percutaneous mechanical support devices. (a) Intra-aortic balloon pump, (b) Impella, (c)TandemHeart, and (d) Veno-arterial (VA) extracorporeal membrane oxygenation (ECMO).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Thiele H., Ohman E.M., De Waha-Thiele S., Zeymer U., Desch S. Management of cardiogenic shock complicating myocardial infarction: An update 2019. Eur. Heart J. 2019;40:2671–2683. doi: 10.1093/eurheartj/ehz363. - DOI - PubMed
    1. Osman M., Syed M., Patibandla S., Sulaiman S., Kheiri B., Shah M.K., Bianco C., Balla S., Patel B. Fifteen-Year Trends in Incidence of Cardiogenic Shock Hospitalization and In-Hospital Mortality in the United States. J. Am. Heart Assoc. 2021;10:e021061. doi: 10.1161/JAHA.121.021061. - DOI - PMC - PubMed
    1. Kolte D., Khera S., Aronow W.S., Mujib M., Palaniswamy C., Sule S., Jain D., Gotsis W., Ahmed A., Frishman W.H., et al. Trends in Incidence, Management, and Outcomes of Cardiogenic Shock Complicating ST-Elevation Myocardial Infarction in the United States. J. Am. Heart Assoc. 2014;3:e000590. doi: 10.1161/JAHA.113.000590. - DOI - PMC - PubMed
    1. Aissaoui N., Puymirat E., Delmas C., Ortuno S., Durand E., Bataille V., Drouet E., Bonello L., Bonnefoy-Cudraz E., Lesmeles G., et al. Trends in cardiogenic shock complicating acute myocardial infarction. Eur. J. Heart Fail. 2020;22:664–672. doi: 10.1002/ejhf.1750. - DOI - PubMed
    1. Jeger R., Radovanovic D., Hunziker P.R., Pfisterer M.E., Stauffer J.-C., Erne P., Urban P. For the AMIS Plus Registry Investigators Ten-year trends in the incidence and treatment of cardiogenic shock. Ann. Intern. Med. 2008;149:618–626. doi: 10.7326/0003-4819-149-9-200811040-00005. - DOI - PubMed

LinkOut - more resources